Obesity Drugs Show Early Promise Against PCOS

Source Summary

Obesity medications are demonstrating early promise in treating polycystic ovary syndrome (PCOS), a condition characterized by weight gain, irregular menstrual periods, and excessive facial hair. The case of Charlotte Touzalin, who experienced these symptoms as a teenager similar to those her mother had struggled with for decades, illustrates the potential of these drugs in addressing PCOS symptoms.